Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Ras, RhoA, and vascular pharmacology in neurodevelopment and aging
Ruth Nussinov
*
, Hyunbum Jang
, Feixiong Cheng
*
Corresponding author for this work
Human Molecular Genetics Biochemistry
National Institutes of Health
Cleveland Clinic Foundation
Case Western Reserve University
Research output
:
Contribution to journal
›
Review article
›
peer-review
1
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Ras, RhoA, and vascular pharmacology in neurodevelopment and aging'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Aging
100%
Alzheimer's Disease
33%
Anti-Alzheimer Drugs
66%
Autism
33%
Autism Spectrum Disorder
33%
Brain Aging
33%
Brain Development
33%
Cardiovascular System
33%
Cell Behavior
33%
Cell Proliferation
33%
Cell Transformation
33%
Cerebral Vasculature
33%
Dilated Cardiomyopathy
33%
Dysregulated
33%
Germ Cells
33%
Immune System
33%
Neurodegeneration
33%
Neurodegenerative Diseases
33%
Neurodevelopment
100%
Neurodevelopmental Disorders
100%
Neurology
33%
Organ System Pathology
33%
Pediatric Low-grade Glioma
33%
Pharmacological Targets
33%
Pharmacology
66%
Ras Small GTPases
33%
Ras Superfamily
33%
RASopathies
33%
Rho GTPases
33%
RhoA
100%
RhoA Signaling
33%
Signaling Pathway
33%
Vascular Pharmacology
100%
Vascular System
66%
Medicine and Dentistry
Alzheimer's Disease
75%
Autism
25%
Brain Development
25%
Cardiovascular System
25%
Cell Function
25%
Cell Proliferation
25%
Cell Signaling Pathway
25%
Cell Transformation
25%
Degenerative Disease
25%
Dilated Cardiomyopathy
25%
Disease
75%
Disease Activity
25%
Diseases
25%
Ganglioglioma
25%
Germ Cell
25%
Immune System Pathology
25%
Nerve Cell Differentiation
100%
Neurodegeneration
25%
Neurology
25%
Pediatrics
25%
Pervasive Developmental Disorder
25%
Pharmacological Target
25%
Ras Signaling
100%
Rho Guanine Nucleotide Binding Protein
25%
Small GTPase
25%
Vascular System
50%
Vascularity
25%
Neuroscience
Alzheimer's Disease
100%
Autism
33%
Brain Development
33%
Cardiovascular System
33%
Cell Function
33%
Cell Proliferation
33%
Cell Transformation
33%
Dilated Cardiomyopathy
33%
Germ Cell
33%
Low-Grade Glioma
33%
Nerve Cell Differentiation
100%
Neurodegeneration
33%
Neurodegenerative Disorder
33%
Pervasive Developmental Disorder
33%
Psychopathology
100%
Ras Protein
33%
Ras Superfamily
33%
RASopathies
33%
Rho Guanine Nucleotide Binding Protein
33%
Biochemistry, Genetics and Molecular Biology
Brain Development
50%
Cell Function
50%
Cell Proliferation
50%
Cell Transformation
50%
Germ Cell
50%
Germline
50%
GTPase
50%
Isoform
50%
Nerve Cell Differentiation
100%
Ras Superfamily
50%
Small GTPase
50%
Vascularization
50%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
100%
Congestive Cardiomyopathy
33%
Degenerative Disease
33%
Disease Activity
33%
Diseases
33%
Mental Diseases
100%
Nerve Degeneration
33%
Ras Protein
33%
Rho Guanine Nucleotide Binding Protein
33%